In patients with RA, TNF inhibitor use during the 3 years after being diagnosed with early-stage lung, colorectal, or prostate cancer was not linked to decreased survival.

Cardiac problems associated with vascular endothelial growth factor inhibitors occur frequently in patients with cancer.

A laboratory on Long Island has found a breakthrough in the fight against pancreatic cancer that can “intercept” its spread.

Kanazawa University and colleagues have developed a promising new approach to cancer treatment. By using tiny, naturally ...

Converging computational and laboratory technologies are helping anti-cancer immune responses hit their target more ...

These biologics, which include monoclonal antibodies, cancer growth inhibitors, gene therapies, and vaccines, among others, have revolutionized the way cancer is treated. The significance of the ...

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients ...

Researchers have explored the evolution of the genetic change that causes chronic myeloid leukaemia and show its ability to drive the disease.

Ovarian cancer, a leading cause of death among gynecological malignancies, has a poor prognosis and low 5-year survival rate, ...

Janus kinase (JAK) inhibitors are associated with an increased risk for lung cancer but not overall cancer among older patients in the United States with rheumatoid arthritis (RA), according to study ...

Cancer Monoclonal Antibody Market Cancer rates continue to rise, especially in aging populations and areas affected by pollution and lifest ...